ArticleJournal of pediatric endocrinology & metabolism : JPEM2025
Impact of growth hormone therapy on bone and body composition in prepubertal children with idiopathic short stature.
Article in Journal of pediatric endocrinology & metabolism : JPEM, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Multiple clinical effects of recombinant human growth hormone therapy].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesFew studies have investigated the effect of growth hormone (GH) therapy on bone health and body composition in children with idiopathic short stature (ISS). Therefore, this study aimed to evaluate the short-term effects of GH treatment on bone mineral density (BMD) and prepubertal body composition in children with ISS.
methodsThe study included 53 prepubertal children with ISS (mean age, 6.3 ± 1.5 years). Their BMD was compared to that of 20 healthy prepubertal children matched for chronological age. Of the 53 children with ISS, 11 received GH therapy for 1 year. Anthropometric measurements and bone age assessments were conducted, and body composition was analyzed using dual-energy X-ray absorptiometry at 6-month intervals.
resultsAt baseline, lumbar spine and femoral neck BMD Z scores, adjusted for height, showed no significant differences between the ISS and control groups. However, bone mineral apparent density (BMAD) Z scores were significantly lower in children with ISS compared to controls. Over 12 months of GH therapy, no significant changes were observed in lumbar spine or femoral neck height-adjusted BMD Z scores. Nevertheless, GH treatment led to a significant reduction in percent body fat for chronological age and an increase in lean body mass after 1 year.
conclusionsPrepubertal children with ISS exhibited lower BMAD at the lumbar spine compared to healthy controls. Although short-term GH therapy did not significantly alter bone density, it positively impacted body composition. These findings provide valuable clinical insights into bone health and body composition in children with ISS.
Indexed as
Identifiers
40256906What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.